Wenjie Jiang

Wenjie Jiang

Auto-generated profile, based on publicly available information

Wenjie Jiang

School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, 31 Bei Ji Ge San Tiao, Beijing, 100730, China, 86 010-65120552

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
WJWenjie Jiang
Wenjie Jiang
HZHao Zhang
Hao Zhang
ZLZhongjie Li
Zhongjie Li
XJXinli Jiang
Xinli Jiang
JSJiamei Shao
Jiamei Shao
ZLZhongjie Li
Zhongjie Li
Background: In resource-limited areas, severe shortages of radiologists contribute to high rates of missed pulmonary tuberculosis (PTB) cases when relying solely on conventional chest X-ray (CXR). Although artificial intelligence–powered computer-aided detection (CAD) has proven effective in PTB diagnosis, its real-world performance remains underexplored. Objective: This study aimed to evaluate the real-world diagnostic yield of CAD technology as a triage tool for detecting PTB in primary health care facilities in high-burden areas. Methods: We conducted a retrospective paired-design diagnostic yield study using CXR images collected from 7 county- and 32 township-level health care facilities in Yichang city between 2022 and 2024 year. All images were retrospectively reprocessed with CAD software (JF CXR-1), and the original reports interpreted by radiologists at the time of patient admission were extracted. CAD and radiologist performances were compared using 2 primary evaluation indicators—diagnostic yield among diagnosed cases (DYD) and positive predictive value (PPV). Subgroup analysis (by region, age, sex, health care facility tier, and patient category) and sensitivity analysis were conducted to assess the robustness of the results. Results: Among 93,319 enrolled study patients, including 273 (0.3%) bacteriologically confirmed PTB cases, CAD demonstrated a substantially higher DYD (229/273, 83.9%) than radiologists (70/273, 25.6%), although the PPV was much lower (1.70% vs 10.31%). This high-sensitivity performance achieved an 85.5% (79,804/93,319) reduction (only 13,515 instead of 93,319 CXRs) in radiologist workload via selective review of CAD-positive images, without missing any radiologist-identified PTB cases. Furthermore, probability scores greater than 0.75 were a key threshold for identifying high-risk patients with PTB, and these patients were prioritized for radiologist review. Subgroup analysis further revealed that CAD outperformed radiologists in identifying PTB cases across all scenarios, despite some heterogeneity. CAD performance was significantly better in township-level medical facilities (DYD: 86.7%; PPV: 2%) than in county-level hospitals (DYD: 62.5%; PPV: 0.6%). Conclusions: CAD technology is valuable for detecting PTB in primary health care facilities. Combined with a tiered artificial intelligence prescreening with selective human review strategy, this approach effectively alleviates the workload of radiologists in resource-constrained regions, offering a scalable solution for tuberculosis prevention and control.

27 August 2025 in JMIR Preprints
Verified
Preprint
Open access
WJWenjie Jiang
Wenjie Jiang
HZHao Zhang
Hao Zhang
ZLZhili Li
Zhili Li
XJXinli Jiang
Xinli Jiang
JSJiamei Shao
Jiamei Shao
ZLZhongjie Li
Zhongjie Li
BACKGROUND In resource-limited areas, severe shortages of radiologist contribute to high rates of missed pulmonary tuberculosis (PTB) cases when relying solely on conventional chest X-ray (CXR). Although artificial intelligence (AI)-powered computer-aided detection (CAD) has shown effective in PTB diagnosis, its real-world clinical utility and scalability in primary healthcare settings remained underexplored. OBJECTIVE To evaluate the real-world performance of CAD technology for triaging of PTB patients in primary healthcare facilities in high-incidence areas, and to assess its potential for optimizing radiological resource allocation. METHODS We conducted a retrospective paired-design diagnostic accuracy study using CXR images collected from 7 county- and 32 township-level healthcare facilities in Yichang city between 2022 and 2024. All images were retrospectively reprocessed with CAD software (JF CXR-1 v2), and the original radiology reports interpreted by radiologists were extracted. CAD and radiologist performances were compared using two primary evaluation indicators: diagnostic yield among diagnosed cases (DYD) and positive predictive value (PPV). Subgroup analysis (by region, age, sex, healthcare facility tier, and patients category) and sensitivity analysis were conducted to assess the robustness of the results. RESULTS Among 93,319 enrolled study patients (including 273 bacteriologically confirmed PTB cases), CAD demonstrated a substantially higher DYD (83.88%, 229/273) than radiologists (25.64%, 70/273), though with much lower PPV (1.70% vs. 10.31%). This high-sensitivity performance achieved an 85.52% reduction (only 13,515 instead of 93,319 CXRs) in radiologist workload via selective review of CAD-positive images, without missing any radiologist-identified PTB cases. Furthermore, among CAD-positive images, probability scores >0.75 was a key threshold for identifying high-risk PTB patients, prioritizing for radiologist review. Subgroup analysis further revealed that CAD outperformed radiologists in identifying PTB cases across all scenarios, despite some heterogeneity. In township healthcare facilities, CAD demonstrated significantly better performance than in county-level facilities, with DYD of 86.72% and 62.50%, and PPV of 2.00% and 0.65%, respectively. CONCLUSIONS CAD technology demonstrates valuable PTB screening performance in primary healthcare facilities. Combined with a tiered "AI pre-screening with selective human review" strategy, this approach effectively alleviates workload of radiologist in resource-constrained regions, offering a scalable solution for tuberculosis prevention and control.